Omicron BQ, XBB subvariants are a serious threat to boosters and knock out antibody treatments, study finds
The latest omicron subvariants could cause a surge of breakthrough infections and reinfections, a new study finds.
The latest omicron subvariants could cause a surge of breakthrough infections and reinfections, a new study finds.
Walgreens is making a splash in primary care. John Driscoll, head of the company’s healthcare business, tells MarketWatch what to expect in 2023.
The head of the WHO is 'hopeful' that 2023 will bring an end to COVID as a global health emergency
The Federal Reserve on Wednesday raised its benchmark rate by 0.5 percentage point and projects at terminal rate of 5.25% next year.
Charter Communications Inc. has big spending plans, and that has some investors heading for the hills
The BoE will deliver its decision at 7 a.m. and the ECB at 8:15 a.m. Eastern on Thursday.
Oil futures finished higher on Wednesday, finding support after the International Energy Agency raised its 2022 and 2023 forecasts for oil demand growth. Data from...
The Fed's task of bringing inflation back down is much easier this time than it was in the late 1970s and early 1980s, writes Alan...
A strategy of holding stocks that have been on an upswing has outperformed the S&P 500 over the long term.